These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31521680)

  • 41. Primary care of the patient with chronic obstructive pulmonary disease in Italy.
    Cazzola M; Bettoncelli G; Sessa E; Cricelli C
    Respir Med; 2009 Apr; 103(4):582-8. PubMed ID: 19103479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An integrated approach to the medical treatment of chronic obstructive pulmonary disease.
    Rosenberg SR; Kalhan R
    Med Clin North Am; 2012 Jul; 96(4):811-26. PubMed ID: 22793946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
    Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
    Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of heart failure in real-world clinical practice: findings from the REFLECT-HF registry in patients with NYHA class II symptoms and a reduced ejection fraction.
    Böhm M; Tschöpe C; Wirtz JH; Lokies J; Turgonyi E; Bramlage P; Lins K; Strunz AM; Tebbe U
    Clin Cardiol; 2015 Apr; 38(4):200-7. PubMed ID: 25733185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Sirak TE; Jelic S; Le Jemtel TH
    J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic.
    Chavez PC; Shokar NK
    COPD; 2009 Dec; 6(6):446-51. PubMed ID: 19938968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β
    Skolnik NS; Nguyen TS; Shrestha A; Ray R; Corbridge TC; Brunton SA
    Postgrad Med; 2020 Mar; 132(2):198-205. PubMed ID: 31900019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multicentric study on the beta-blocker use and relation with exacerbations in COPD.
    Puente-Maestu L; Calle M; Ortega-González A; Fuster A; González C; Márquez-Martín E; Marcos-Rodriguez PJ; Calero C; Rodríguez-Hermosa JL; Malo de Molina R; Aburto M; Sobradillo P; Alcázar B; Tirado-Conde G;
    Respir Med; 2014 May; 108(5):737-44. PubMed ID: 24635914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The delicate choice of optimal basic therapy for multimorbid older adults: A cross-sectional survey.
    Sirois C; Lunghi C; Laroche ML; Maheux A; Frini A
    Res Social Adm Pharm; 2019 Jun; 15(6):761-766. PubMed ID: 30249377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Asthma and COPD: guidance in the jungle of inhalative drugs].
    Hering T
    MMW Fortschr Med; 2015 May; 157(10):59, 61-2. PubMed ID: 26019099
    [No Abstract]   [Full Text] [Related]  

  • 53. COPD in 2016: some answers, more questions.
    Labaki WW; Martinez CH; Han MK
    Lancet Respir Med; 2016 Dec; 4(12):941-943. PubMed ID: 27890500
    [No Abstract]   [Full Text] [Related]  

  • 54. [Drugs for chronic obstructive pulmonary disorder].
    Bakke PS; Høines KJ
    Tidsskr Nor Laegeforen; 2019 Oct; 139(14):. PubMed ID: 31592602
    [No Abstract]   [Full Text] [Related]  

  • 55. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit.
    Jones RC; Dickson-Spillmann M; Mather MJ; Marks D; Shackell BS
    Respir Res; 2008 Aug; 9(1):62. PubMed ID: 18710575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-life evaluation of COPD treatment in a Bulgarian population: a 1-year prospective, observational, noninterventional study.
    Ivanov Y; Nikolaev I; Nemeth I
    Int J Chron Obstruct Pulmon Dis; 2018; 13():653-663. PubMed ID: 29503539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
    Mentz RJ; Fiuzat M; Wojdyla DM; Chiswell K; Gheorghiade M; Fonarow GC; O'Connor CM
    Eur J Heart Fail; 2012 Apr; 14(4):395-403. PubMed ID: 22302663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
    Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Thach C; Patalano F; Banerji D;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1015-26. PubMed ID: 26082625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
    Sessa M; Mascolo A; Rasmussen DB; Kragholm K; Jensen MT; Sportiello L; Rafaniello C; Tari GM; Pagliaro C; Andersen M; Rossi F; Capuano A
    Sci Rep; 2019 Aug; 9(1):11465. PubMed ID: 31391573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise.
    Chang CL; Mills GD; McLachlan JD; Karalus NC; Hancox RJ
    Intern Med J; 2010 Mar; 40(3):193-200. PubMed ID: 19383058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.